• SENSEX 76,496.76
    -258.29 (--0.34%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
  • Bharti Airtel
    1,936.05 1,745.00(%)
  • Bluestone Jewel
    832.00 872.60(%)
  • Gandhar Oil Ref.
    283.85 245.00(%)
  • Oracle Fin.Serv.
    11,394.75 11,986.90(%)
  • Dr Reddy's Labs
    1,080.05 1,149.00(%)
  • SBI Funds Mgt.
    575.35 582.55(%)
  • Eternal
    291.30 368.40(%)
  • Kalyan Jewellers
    602.00 617.30(%)
  • Tanla Platforms
    625.45 765.75(%)
  • Nippon ETF Liq.
    1,000.01 1,010.50(%)
  • Data Pattern
    4,672.60 2,131.00(%)
  • Adani Green
    1,403.00 767.00(%)
  • Millworks Technologies
    727.95 693.30(%)
  • H P C L
    376.80 316.20(%)
  • HDFC Bank
    746.00 726.75(%)
  • Cupid
    211.00 225.90(%)
  • Wakefit Innovati
    147.95 223.95(%)
  • Dixon Technolog.
    13,971.95 18,471.50(%)
  • Reliance Industries
    1,277.85 1,253.65(%)
  • Uflex
    515.00 609.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bharat Parenterals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3882.0
  • ISIN : INE365Y01019
1,480.45 -5 (-0.34%)
  • As on 23 Jul 2026 (EOD)
  • Today’s Low

    1,459.95
  • Today’s High

    1,509.50
  • Open

    1,500.00
  • Perv Close

    1,485.50
  • 52W Low

    880.25
  • 52W High

    1,667.20

Key Indicators

  • P/E(TTM)

    63.70

  • Mar.Cap (₹Cr.)

    1,020.32

  • Div & Yield %

    0.07

  • Book Value(₹)

    583.78

  • Debt-Equity Ratio

    -0.34

  • AGM Date

    22-Jul-2026

  • EPS

    23.24

  • P/E Ratio

    63.70

Financials Ratios

  • Debt-Equity Ratio

    0.55

  • Mar.Cap (₹Cr.)

    1,020.32

  • RONW (%)

    5.53

  • ROCE (%)

    7.69

Score Board

  • Equity (₹ in Cr.)

    6.89

  • BV (₹)

    583.80

  • Sales( ₹ in Cr.)

    234.01

  • NP (in Cr.)

    16.02

  • NP Var(%)

    -41.0

  • Div%

    10.0

  • CPS (₹)

    35.40

  • EPS (₹)

    23.20

  • Traded Value (₹ in Lakhs)

    1,020.32

  • 52 Week High

    1,667.20

  • 52 Week Low

    880.25

  • Price BSE

    1480.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    1,020.32

  • P/C Ratio

    41.80

  • P/E Ratio

    63.70

  • Price Vs.BV

    23.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 304.13 257.98 252.73 240.92 203.67 226.33
Excise Duty 0.00 0.00 34.75 28.91 0.00 0.00
Net Sales 304.13 257.98 217.98 212.01 203.67 226.33
Other Income 14.55 8.04 18.84 7.78 8.67 11.48
Stock Adjustments -10.14 15.19 9.75 -1.68 -1.88 3.27
Total Income 308.54 281.21 246.57 218.11 210.46 241.08
EXPENDITURE :            
Raw Materials 179.46 173.71 147.23 134.39 132.16 150.50
Power and Fuel Cost 4.63 4.24 3.73 2.98 3.10 3.19
Employee Cost 21.38 19.62 16.93 15.26 14.39 14.11
Other Manufacturing Expenses 13.07 11.29 10.06 7.42 6.39 7.00
Selling and Administration Expenses 34.59 26.79 23.54 13.82 13.77 20.90
Miscellaneous Expenses 7.26 4.58 4.50 7.91 6.85 3.68
Employee Benefit Expenses 21.38 19.62 16.93 15.26 14.39 14.11
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 260.39 240.22 205.99 181.78 176.66 199.38
Operating Profit 48.16 41.00 40.59 36.34 33.81 41.70
Interest 4.79 3.80 2.57 1.31 0.76 0.86
Gross Profit 43.37 37.20 38.02 35.03 33.05 40.84
Depreciation 7.05 6.40 5.85 6.66 6.03 5.88
Profit Before Tax 36.32 30.80 32.17 28.37 27.02 34.96
Current Tax 10.58 8.66 8.40 8.01 7.09 9.82
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.72 -0.45 -0.57 -0.94 -0.28 -1.17
Reported Net Profit 26.45 22.59 24.34 21.30 20.21 26.30
Extraordinary Items -0.71 -0.03 4.55 -0.53 0.16 -0.30
Adjusted Net Profit 27.16 22.62 19.79 21.83 20.05 26.60
Adjustment below Net Profit 0.06 -0.20 0.04 -0.23 0.16 0.04
P & L Balance brought forward 205.16 183.19 158.81 137.74 117.37 91.03
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.58 0.43 0.00 0.00 0.00 0.00
P & L Balance carried down 231.09 205.16 183.19 158.81 137.74 117.37
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 7.50 0.00 0.00 0.00
Dividend Per Share(Rs) 1.00 1.00 0.75 0.00 0.00 0.00
Earnings Per Share-Unit Curr 38.38 38.82 42.14 36.89 35.27 45.90
Earnings Per Share(Adj)-Unit Curr 38.38 38.82 42.14 36.89 35.27 45.90
Book Value 561.27 367.05 330.86 287.72 251.22 214.92
Book Value(Adj)-Unit Curr 561.27 367.05 330.86 287.72 251.22 214.92

Shareholding Pattern

  • Promoter Group

    67.20%

  • Public Share Holding

    32.80%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,750,053 39.90 2,750,053 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,881,598 27.30 1,881,598 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,631,651 67.20 4,631,651 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 500 0.01 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,500 0.11 7,500 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 94,180 1.37 94,180 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 102,180 1.48 101,680 5
2] Non Institution
Bodies Corporate 567,311 8.23 221,781 43
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 254,998 3.70 248,498 51
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 57,513 0.83 54,313 86
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 350,994 5.09 350,994 5
Individuals holding nominal share capital up to Rs. 1 lakh 926,565 13.44 748,040 2,859
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 751 0.01 751 1
Others 0 0.00 0 0
Sub Total 2,158,132 31.31 1,624,377 3,045
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,891,963 100.00 6,357,708 3,059

Company Background

Bharat Parenterals LtdPharmaceuticals - Indian - Formulations

  • Bharat Parenterals Ltd
  • BSE Code : 3882.0
  • ISIN : INE365Y01019
  • Incorporation Year

    1992

  • Registered Office

    Survey No 144 & 146 Haripura
    Jarod Samlaya Road Tal Savli, Vadodara,
    Gujarat-391520

  • Telephone

    91-2667-251679

  • FAX

    91-2667-251670

  • Chairman

    Bharat Kumar R Desai

  • Managing Director

  • Company Secretary

    Sharmin Nareshkumar Soni

  • Auditor

    Shah Mehta & Bakshi

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Adroit Corporate Serv. Pvt Ltd
    205/206 Sterling Cen,
    R C Dutt Road ,Alkapuri
    Mumbai - Vadodara - 390007

Bharat Parenterals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bharat Parenter. 1,480.45 318.68 304.13 63.70 10.88
P & G Health Ltd 6,718.20 944.52 934.17 34.11 71.75
Sanofi India 3,403.50 1,857.10 1,837.40 25.30 54.17
Glaxosmi. Pharma 2,551.10 3,932.76 3,790.20 42.71 58.17
J B Chemicals & 2,412.25 3,945.17 3,889.89 57.46 24.24
Novartis India 1,699.05 398.23 356.27 45.02 16.64
Cipla 1,415.10 20,102.60 18,979.95 32.52 13.88
Amrutanjan Healt 529.35 469.50 451.82 26.43 21.89
Bliss GVS Pharma 448.15 773.53 729.81 49.09 12.51
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 31.49 19.52 3.94 22.02 6.77